A phase 1/2, first-in-human study of STX-478 monotherapy or in combination with fulvestrant in patients with breast cancer or other advanced solid tumors (trial in progress)

被引：0
|
作者：
Montero, Alberto
Orr, Douglas
Munster, Pamela
LoRusso, Patricia
Jhaveri, Komal
Pluard, Timothy
Winer, Ira
Streit, Michael
Patterson, Monica
Roberts, Simon
Corsi-Travali, Stefani
Ewert, Courtney
Juric, Dejan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-20-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-20-04
引用
收藏
页数：4
相关论文
共 50 条
  • [21] First-in-human phase 1/2a trial of a macrocyclic ATR inhibitor (ATRN-119) in patients with advanced solid tumors
    Simpkins, Fiona
    Mahipal, Amit
    LoRusso, Patricia
    Schneider, Reva
    Miller, Crystal
    Stenehjem, David
    Brown, Eric J.
    Carleton, Mike
    Gullbo, Joachim
    Mirza, Nadeem Q.
    CANCER RESEARCH, 2024, 84 (07)
  • [22] A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors
    Tabernero, Josep
    Dirix, Luc
    Schoffski, Patrick
    Cervantes, Andres
    Antonio Lopez-Martin, Jose
    Capdevila, Jaume
    van Beijsterveldt, Ludy
    Platero, Suso
    Hall, Brett
    Yuan, Zhilong
    Knoblauch, Roland
    Zhuang, Sen Hong
    CLINICAL CANCER RESEARCH, 2011, 17 (19) : 6313 - 6321
  • [23] First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors
    Elez, Elena
    Gomez-Roca, Carlos
    Soto Matos-Pita, Arturo
    Argiles, Guillem
    Valentin, Thibaud
    Coronado, Cinthya
    Iglesias, Jorge
    Macarulla, Teresa
    Betrian, Sarah
    Fudio, Salvador
    Zaragoza, Katrin
    Tabernero, Josep
    Delord, Jean-Pierre
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 674 - 683
  • [24] First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors
    Elena Elez
    Carlos Gomez-Roca
    Arturo Soto Matos-Pita
    Guillem Argiles
    Thibaud Valentin
    Cinthya Coronado
    Jorge Iglesias
    Teresa Macarulla
    Sarah Betrian
    Salvador Fudio
    Katrin Zaragoza
    Josep Tabernero
    Jean-Pierre Delord
    Investigational New Drugs, 2019, 37 : 674 - 683
  • [25] Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours
    Powderly, J.
    Shimizu, T.
    Lorusso, P.
    Razak, A.
    Miller, K. D.
    Balar, A. V.
    Bruix, J.
    Michel, L. S.
    Blaney, M.
    Guan, X.
    Lacy, S.
    Lally, S.
    Lambert, S.
    Leibman, R.
    Vosganian, G.
    Golan, T.
    Tolcher, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S499 - S499
  • [26] A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
    Daphne Day
    John J. Park
    Jermaine Coward
    Ben Markman
    Charlotte Lemech
    James C. Kuo
    Amy Prawira
    Michael P. Brown
    Sarwan Bishnoi
    Dusan Kotasek
    R. Matthew Strother
    Rasha Cosman
    Rila Su
    Yiding Ma
    Zenglian Yue
    Hui-han Hu
    Rachel Wu
    Peiqi Li
    Archie N. Tse
    British Journal of Cancer, 2023, 129 : 1608 - 1618
  • [27] First-in-human trial of TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa (BA) in patients (pts) with advanced solid unresectable tumors
    Naing, Aung
    McKean, Meredith
    Tolcher, Anthony
    Victor, Anja
    Hu, Ping
    Mehr, Keyvan Tadjalli
    Kitzing, Thomas
    Holland, Daniel
    Richter, Emilia
    Siu, Lillian
    CANCER RESEARCH, 2024, 84 (07)
  • [28] A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
    Day, Daphne
    Park, John J.
    Coward, Jermaine
    Markman, Ben
    Lemech, Charlotte
    Kuo, James C.
    Prawira, Amy
    Brown, Michael P.
    Bishnoi, Sarwan
    Kotasek, Dusan
    Strother, R. Matthew
    Cosman, Rasha
    Su, Rila
    Ma, Yiding
    Yue, Zenglian
    Hu, Hui-han
    Wu, Rachel
    Li, Peiqi
    Tse, Archie N.
    BRITISH JOURNAL OF CANCER, 2023, 129 (10) : 1608 - 1618
  • [29] First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
    Tao, Jessica J.
    Cangemi, Nicholas A.
    Makker, Vicky
    Cadoo, Karen A.
    Liu, Joyce F.
    Rasco, Drew W.
    Navarro, Willis H.
    Haqq, Christopher M.
    Hyman, David M.
    CLINICAL CANCER RESEARCH, 2019, 25 (18) : 5458 - 5465
  • [30] A first-in-human phase 1, multicenter trial of toll-like receptor (TLR) 7 agonist DSP-0509 as monotherapy and in combination with pembrolizumab in adult patients with advanced solid tumors
    Weiss, Jared
    Olszanski, Anthony
    Berlin, Jordan
    Origuchi, Makoto
    Li, Zhonggai
    Ertik, Bella
    Cai, Hongliang
    Clancy, Daniel
    Iglesias, Jose
    Subbiah, Vivek
    Jalal, Shadia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345